LSV Asset Management
INDV icon

LSV Asset Management’s Indivior Pharmaceuticals INDV Stock Holding History

LSV Asset Management’s Portfolio INDV Stock Details INDV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$11.4M Buy
373,734
+82,600
+28% +$2.73M 0.02% 384
2025
Q4 		$10.4M Buy
291,134
+270,834
+1,334% +$8.27M 0.02% 382
2025
Q3 		$489K Buy
+20,300
New +$425K ﹤0.01% 702

Other funds holding INDV

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
OCM
Oaktree Capital Management Los Angeles, California $6.56B AUM 42.97% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
TSC
Two Seas Capital Rye, New York $7.15B AUM 169.27% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $29.7B AUM 43.33% 1-Year Est. Return
MAP
Madison Avenue Partners New York $2.3B AUM 115.82% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

LSV Asset Management's INDV Position: Q1 2026 in Review

LSV Asset Management increased its Indivior Pharmaceuticals (INDV) stake by 28% in Q1 2026, buying an estimated $2.73M and bringing the position to 373,734 shares worth $11.4M. The position accounts for 0.02% of the portfolio, ranked #384.

LSV Asset Management first reported a position in INDV in Q3 2025 and has held it in 3 quarters since. 289 funds tracked by Wall St. Rank hold INDV as of Q1 2026.

  • LSV Asset Management held 373,734 shares of Indivior Pharmaceuticals worth $11.4M as of Q1 2026.
  • LSV Asset Management bought 82,600 Indivior Pharmaceuticals shares in Q1 2026, an estimated $2.73M.
  • Indivior Pharmaceuticals made up 0.02% of LSV Asset Management's portfolio in Q1 2026, its #384 holding.
  • LSV Asset Management first reported a position in Indivior Pharmaceuticals in Q3 2025 and has held it in 3 quarters since.
  • 289 funds tracked by Wall St. Rank held Indivior Pharmaceuticals as of Q1 2026.

Based on LSV Asset Management's 13F filing for Q1 2026, filed 11 May 2026.